Statistics for CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy
Total visits
views | |
---|---|
CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy | 0 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression_compressed.pdf | 4 |
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration implications in asthma therapy.pdf.pdf | 2 |
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression.pdf | 1 |